vs
Amphastar Pharmaceuticals, Inc.（AMPH）与Concrete Pumping Holdings, Inc.（BBCP）财务数据对比。点击上方公司名可切换其他公司
Amphastar Pharmaceuticals, Inc.的季度营收约是Concrete Pumping Holdings, Inc.的1.9倍（$183.1M vs $98.9M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs 5.4%，领先8.0%），Amphastar Pharmaceuticals, Inc.同比增速更快（-1.8% vs -3.2%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $1.9M），过去两年Concrete Pumping Holdings, Inc.的营收复合增速更高（4.8% vs 3.2%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
Concrete Pumping Holdings, Inc.是领先的混凝土泵送服务及相关设备租赁供应商，主要面向美国和英国市场，业务覆盖基础设施建设、商业地产开发、住宅建造等核心建筑领域，为各类项目提供高效安全的混凝土输送解决方案。
AMPH vs BBCP — 直观对比
营收规模更大
AMPH
是对方的1.9倍
$98.9M
营收增速更快
AMPH
高出1.3%
-3.2%
净利率更高
AMPH
高出8.0%
5.4%
自由现金流更多
AMPH
多$22.7M
$1.9M
两年增速更快
BBCP
近两年复合增速
3.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $98.9M |
| 净利润 | $24.4M | $5.3M |
| 毛利率 | 46.8% | 43.8% |
| 营业利润率 | 19.4% | 17.0% |
| 净利率 | 13.3% | 5.4% |
| 营收同比 | -1.8% | -3.2% |
| 净利润同比 | -35.7% | -43.6% |
| 每股收益（稀释后） | $0.51 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHBBCP
| Q4 25 | $183.1M | $98.9M | ||
| Q3 25 | $191.8M | $94.2M | ||
| Q2 25 | $174.4M | $85.2M | ||
| Q1 25 | $170.5M | $78.0M | ||
| Q4 24 | $186.5M | $102.1M | ||
| Q3 24 | $191.2M | $100.6M | ||
| Q2 24 | $182.4M | $98.7M | ||
| Q1 24 | $171.8M | $90.0M |
净利润AMPHBBCP
| Q4 25 | $24.4M | $5.3M | ||
| Q3 25 | $17.4M | $3.7M | ||
| Q2 25 | $31.0M | $-4.0K | ||
| Q1 25 | $25.3M | $-2.6M | ||
| Q4 24 | $38.0M | $9.4M | ||
| Q3 24 | $40.4M | $7.6M | ||
| Q2 24 | $37.9M | $3.0M | ||
| Q1 24 | $43.2M | $-3.8M |
毛利率AMPHBBCP
| Q4 25 | 46.8% | 43.8% | ||
| Q3 25 | 51.4% | 42.9% | ||
| Q2 25 | 49.6% | 42.5% | ||
| Q1 25 | 50.0% | 40.0% | ||
| Q4 24 | 46.5% | 45.3% | ||
| Q3 24 | 53.3% | 44.3% | ||
| Q2 24 | 52.2% | 42.3% | ||
| Q1 24 | 52.4% | 37.0% |
营业利润率AMPHBBCP
| Q4 25 | 19.4% | 17.0% | ||
| Q3 25 | 13.2% | 13.7% | ||
| Q2 25 | 24.2% | 9.7% | ||
| Q1 25 | 21.9% | 4.5% | ||
| Q4 24 | 24.2% | 18.8% | ||
| Q3 24 | 29.8% | 16.5% | ||
| Q2 24 | 30.3% | 12.2% | ||
| Q1 24 | 27.9% | 1.6% |
净利率AMPHBBCP
| Q4 25 | 13.3% | 5.4% | ||
| Q3 25 | 9.0% | 3.9% | ||
| Q2 25 | 17.8% | -0.0% | ||
| Q1 25 | 14.8% | -3.4% | ||
| Q4 24 | 20.4% | 9.2% | ||
| Q3 24 | 21.1% | 7.5% | ||
| Q2 24 | 20.8% | 3.1% | ||
| Q1 24 | 25.1% | -4.3% |
每股收益（稀释后）AMPHBBCP
| Q4 25 | $0.51 | $0.09 | ||
| Q3 25 | $0.37 | $0.07 | ||
| Q2 25 | $0.64 | $-0.01 | ||
| Q1 25 | $0.51 | $-0.06 | ||
| Q4 24 | $0.74 | $0.16 | ||
| Q3 24 | $0.78 | $0.13 | ||
| Q2 24 | $0.73 | $0.05 | ||
| Q1 24 | $0.81 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $44.4M |
| 总债务越低越好 | $608.7M | $417.9M |
| 股东权益账面价值 | $788.8M | $264.8M |
| 总资产 | $1.6B | $879.5M |
| 负债/权益比越低杠杆越低 | 0.77× | 1.58× |
8季度趋势，按日历期对齐
现金及短期投资AMPHBBCP
| Q4 25 | $282.8M | $44.4M | ||
| Q3 25 | $276.2M | $41.0M | ||
| Q2 25 | $231.8M | $37.8M | ||
| Q1 25 | $236.9M | $85.1M | ||
| Q4 24 | $221.6M | $43.0M | ||
| Q3 24 | $250.5M | $26.3M | ||
| Q2 24 | $217.8M | $18.0M | ||
| Q1 24 | $289.6M | $14.7M |
总债务AMPHBBCP
| Q4 25 | $608.7M | $417.9M | ||
| Q3 25 | $608.6M | $417.6M | ||
| Q2 25 | $607.7M | $417.3M | ||
| Q1 25 | $603.9M | $417.1M | ||
| Q4 24 | $601.6M | $373.3M | ||
| Q3 24 | $596.4M | $372.9M | ||
| Q2 24 | $586.9M | $372.6M | ||
| Q1 24 | $594.0M | $372.2M |
股东权益AMPHBBCP
| Q4 25 | $788.8M | $264.8M | ||
| Q3 25 | $776.7M | $261.3M | ||
| Q2 25 | $757.5M | $261.8M | ||
| Q1 25 | $751.3M | $260.7M | ||
| Q4 24 | $732.3M | $321.7M | ||
| Q3 24 | $727.7M | $314.7M | ||
| Q2 24 | $713.3M | $308.3M | ||
| Q1 24 | $672.4M | $307.9M |
总资产AMPHBBCP
| Q4 25 | $1.6B | $879.5M | ||
| Q3 25 | $1.7B | $886.0M | ||
| Q2 25 | $1.6B | $878.8M | ||
| Q1 25 | $1.6B | $912.9M | ||
| Q4 24 | $1.6B | $898.0M | ||
| Q3 24 | $1.5B | $890.8M | ||
| Q2 24 | $1.5B | $894.7M | ||
| Q1 24 | $1.6B | $894.8M |
负债/权益比AMPHBBCP
| Q4 25 | 0.77× | 1.58× | ||
| Q3 25 | 0.78× | 1.60× | ||
| Q2 25 | 0.80× | 1.59× | ||
| Q1 25 | 0.80× | 1.60× | ||
| Q4 24 | 0.82× | 1.16× | ||
| Q3 24 | 0.82× | 1.19× | ||
| Q2 24 | 0.82× | 1.21× | ||
| Q1 24 | 0.88× | 1.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $14.5M |
| 自由现金流经营现金流 - 资本支出 | $24.6M | $1.9M |
| 自由现金流率自由现金流/营收 | 13.4% | 1.9% |
| 资本支出强度资本支出/营收 | 4.5% | 12.7% |
| 现金转化率经营现金流/净利润 | 1.35× | 2.72× |
| 过去12个月自由现金流最近4个季度 | $121.2M | $17.5M |
8季度趋势，按日历期对齐
经营现金流AMPHBBCP
| Q4 25 | $32.9M | $14.5M | ||
| Q3 25 | $52.6M | $19.1M | ||
| Q2 25 | $35.6M | $24.7M | ||
| Q1 25 | $35.1M | $6.0M | ||
| Q4 24 | $29.0M | $22.4M | ||
| Q3 24 | $60.0M | $35.0M | ||
| Q2 24 | $69.1M | $9.1M | ||
| Q1 24 | $55.3M | $20.3M |
自由现金流AMPHBBCP
| Q4 25 | $24.6M | $1.9M | ||
| Q3 25 | $47.2M | $4.3M | ||
| Q2 25 | $25.0M | $11.1M | ||
| Q1 25 | $24.4M | $191.0K | ||
| Q4 24 | $16.6M | $16.1M | ||
| Q3 24 | $46.2M | $26.4M | ||
| Q2 24 | $63.1M | $-1.9M | ||
| Q1 24 | $46.5M | $2.5M |
自由现金流率AMPHBBCP
| Q4 25 | 13.4% | 1.9% | ||
| Q3 25 | 24.6% | 4.6% | ||
| Q2 25 | 14.3% | 13.0% | ||
| Q1 25 | 14.3% | 0.2% | ||
| Q4 24 | 8.9% | 15.8% | ||
| Q3 24 | 24.1% | 26.2% | ||
| Q2 24 | 34.6% | -1.9% | ||
| Q1 24 | 27.1% | 2.8% |
资本支出强度AMPHBBCP
| Q4 25 | 4.5% | 12.7% | ||
| Q3 25 | 2.8% | 15.7% | ||
| Q2 25 | 6.1% | 16.0% | ||
| Q1 25 | 6.3% | 7.5% | ||
| Q4 24 | 6.7% | 6.2% | ||
| Q3 24 | 7.2% | 8.6% | ||
| Q2 24 | 3.3% | 11.2% | ||
| Q1 24 | 5.1% | 19.7% |
现金转化率AMPHBBCP
| Q4 25 | 1.35× | 2.72× | ||
| Q3 25 | 3.03× | 5.16× | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | 2.38× | ||
| Q3 24 | 1.48× | 4.63× | ||
| Q2 24 | 1.82× | 3.00× | ||
| Q1 24 | 1.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
BBCP
| US Concrete Pumping | $72.2M | 73% |
| US Concrete Waste Management Services | $21.3M | 22% |
| Other | $5.4M | 5% |
